PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF

DEFINITIVE CONTRACT won by SIGA TECHNOLOGIES, INC. · work in CORVALLIS, OR
$320,585,761
RecipientSIGA TECHNOLOGIES, INC. UEI VJRNRTSL22K4
Award ID75A50118C00019
Award amount$320,585,761
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN13
Start dateSep 10, 2018
End dateAug 30, 2029
Place of performanceCORVALLIS, OR
Record updatedAug 5, 2022

View the official award record

More awards won by SIGA TECHNOLOGIES, INC.

DRUGS AND BIOLOGICALS
Department of Health and Human Services · $518,482,778 · May 13, 2011
CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20
Department of Health and Human Services · $39,272,196 · Sep 1, 2008
PROCURE UP TO 23000 TPOXX COURSES FOR SMALL POX TREATMENT.
Department of Defense · $11,752,417 · Sep 28, 2022
PROCUREMENT OF 23,030 TPOXX ORAL COURSES AND 50 TPOXX IV COURSES. TO MAINTAIN NATIONAL STOCKPILE.
Department of Defense · $8,999,677 · Aug 2, 2024
PROCURE COURSES OF FDA APPROVED TPOXX DRUG/THERAPEUTIC
Department of Defense · $7,469,638 · May 12, 2022

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids